Development of a Staphylococcus aureus Vaccine: An Ongoing Journey
- PMID: 37119277
- DOI: 10.1093/cid/ciad217
Development of a Staphylococcus aureus Vaccine: An Ongoing Journey
Keywords: Staphylococcus aureus; immunity; vaccine.
Conflict of interest statement
Potential conflicts of interest. R. A. P. reports serving as a paid consultant on the scientific advisory committees for IBT and Telephus, which are developing staphylococcal vaccines; being employed by Merck Research Labs from 2008–2010; consulting fees for Destiny Pharma and the University of Rochester as a consultant; and stock or stock options with Telephus and AmebaGone. The author has submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Comment on
-
Efficacy of a 4-Antigen Staphylococcus aureus Vaccine in Spinal Surgery: The STaphylococcus aureus suRgical Inpatient Vaccine Efficacy (STRIVE) Randomized Clinical Trial.Clin Infect Dis. 2023 Jul 26;77(2):312-320. doi: 10.1093/cid/ciad218. Clin Infect Dis. 2023. PMID: 37125490 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
